Takeda Pharmaceutical (TAK) Other Non-Current Assets: 2018-2025

Historic Other Non-Current Assets for Takeda Pharmaceutical (TAK) over the last 8 years, with Mar 2025 value amounting to $461.4 million.

  • Takeda Pharmaceutical's Other Non-Current Assets rose 33.30% to $460.7 million in Q1 2025 from the same period last year, while for Mar 2025 it was $460.7 million, marking a year-over-year increase of 33.30%. This contributed to the annual value of $461.4 million for FY2025, which is 29.92% up from last year.
  • Per Takeda Pharmaceutical's latest filing, its Other Non-Current Assets stood at $461.4 million for FY2025, which was up 29.92% from $355.1 million recorded in FY2024.
  • Takeda Pharmaceutical's Other Non-Current Assets' 5-year high stood at $946.5 million during FY2021, with a 5-year trough of $355.1 million in FY2024.
  • Over the past 3 years, Takeda Pharmaceutical's median Other Non-Current Assets value was $461.4 million (recorded in 2025), while the average stood at $428.4 million.
  • In the last 5 years, Takeda Pharmaceutical's Other Non-Current Assets slumped by 36.30% in 2023 and then grew by 29.92% in 2025.
  • Over the past 5 years, Takeda Pharmaceutical's Other Non-Current Assets (Yearly) stood at $946.5 million in 2021, then dropped by 22.26% to $735.8 million in 2022, then crashed by 36.30% to $468.7 million in 2023, then dropped by 24.24% to $355.1 million in 2024, then rose by 29.92% to $461.4 million in 2025.